{"product_id":"virus-like-particles-vlps-isotype-control-bhp10516912","title":"Virus-Like Particles (VLPs) isotype control","description":"\u003ch2\u003eOverview\u003c\/h2\u003e \u003cp\u003eThis product is a recombinant VLPs protein commonly used as a defined reagent for assay development, interaction studies, and cell-based functional experiments. \u003c\/p\u003e \u003ch2\u003eKey elements and design rationale\u003c\/h2\u003e \u003cul\u003e \u003cli\u003e\n\u003cstrong\u003eExpression system:\u003c\/strong\u003e Mammalian cell — expression context can influence folding and post-translational features.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eConjugate\/format:\u003c\/strong\u003e C-terminal 10xHis-tagged — useful for platform-specific capture or detection workflows.\u003c\/li\u003e \u003c\/ul\u003e \u003ch2\u003eBiological background\u003c\/h2\u003e \u003cp\u003eVLPs is studied for its biological roles within relevant pathways and cellular contexts. Recombinant reagents enable controlled dosing and binding measurements independent of endogenous expression.\u003c\/p\u003e \u003ch2\u003eResearch relevance and current trends\u003c\/h2\u003e \u003cul\u003e \u003cli\u003eAntigen design for serology assay development and immunoprofiling across cohorts.\u003c\/li\u003e \u003cli\u003eEpitope-focused studies evaluating variant-dependent antigenicity and antibody binding.\u003c\/li\u003e \u003cli\u003eUse of recombinant antigens as benchmarks in neutralization and binding platforms.\u003c\/li\u003e \u003c\/ul\u003e \u003ch2\u003eCommon research applications\u003c\/h2\u003e \u003cul\u003e \u003cli\u003eUse as a reagent for consistent dosing across in vitro assays\u003c\/li\u003e \u003cli\u003eGenerate standard curves or spike-in controls in buffer or sample matrix for plate assays\u003c\/li\u003e \u003cli\u003eUse VLPs as antigen control for serology assay development and immunoreactivity testing\u003c\/li\u003e \u003c\/ul\u003e \u003ch2\u003eNotes for experimental interpretation\u003c\/h2\u003e \u003cul\u003e \u003cli\u003eConsider isoforms, processing, or post-translational modifications that may differ from endogenous protein across systems.\u003c\/li\u003e \u003cli\u003eFor tagged or labeled formats, confirm that the tag does not occlude binding sites relevant to your readout.\u003c\/li\u003e \u003cli\u003eUse appropriate negative\/positive controls and orthogonal assays when interpreting binding or activity differences.\u003c\/li\u003e \u003c\/ul\u003e \u003c!-- Sources (internal): - UniProt Knowledgebase (UniProt): https:\/\/www.uniprot.org\/ - NCBI Gene (NIH\/NCBI): https:\/\/www.ncbi.nlm.nih.gov\/gene\/ - NCBI Protein (NIH\/NCBI): https:\/\/www.ncbi.nlm.nih.gov\/protein\/ - Reactome Pathway Database: https:\/\/reactome.org\/ - KEGG Pathway Database: https:\/\/www.kegg.jp\/ - NCBI Virus (NIH\/NCBI): https:\/\/www.ncbi.nlm.nih.gov\/labs\/virus\/ - ICTV Virus Taxonomy: https:\/\/ictv.global\/ --\u003e","brand":"CUSABIO TECHONOLOGY LLC","offers":[{"title":"1 mg","offer_id":53059852730733,"sku":"CSB-MP3838d7-1MG","price":1770.0,"currency_code":"USD","in_stock":true},{"title":"100 ug","offer_id":53059915219309,"sku":"CSB-MP3838d7-100UG","price":334.0,"currency_code":"USD","in_stock":true},{"title":"20 ug","offer_id":53059915252077,"sku":"CSB-MP3838d7-20UG","price":134.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.ebiohippo.com\/products\/virus-like-particles-vlps-isotype-control-bhp10516912","provider":"BioHippo","version":"1.0","type":"link"}